Statement Of Cash Flows [Abstract]

BioPorto - Filing #5888346

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
89,781,000 DKK
61,799,000 DKK
Cash flows from (used in) operating activities
83,583,000 DKK
55,456,000 DKK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
350,000 DKK
39,000 DKK
Cash flows from (used in) investing activities
1,187,000 DKK
277,000 DKK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
2,547,000 DKK
3,738,000 DKK
Cash flows from (used in) financing activities
75,466,000 DKK
40,790,000 DKK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
6,930,000 DKK
14,943,000 DKK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
192,000 DKK
447,000 DKK
Cash and cash equivalents
59,664,000 DKK
66,402,000 DKK
81,792,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.